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1. Introduction 
Upon Injury, a complex biological response of tissues is initiated to protect the organism 
and remove the injurious stimuli then trigger the healing process. Inflammation is a part of 
this complex response. The local response to tissue injury or infection is acute inflammation. 
Without inflammation, wounds and infections would never heal. This response is called the 
acute-phase response. After the beginning of inflammation, a large number of changes in the 
physiological system occur and last for 1 or 2 days; the system then returns to normal for 4 
to 7 days provided there is no further stimulation. This systemic response is called acute-
phase reaction (APR), also called acute-phase response. APR is characterized by fever and 
by an increased number of peripheral white blood cells. At the same time, cellular and 
biochemical changes occur in liver or other cells. One of the important events in acute-phase 
response is the change of the protein molecules in the plasma, known as the acute-phase 
proteins (APPs) (1–6). 
 
 
Fig. 1. The acute phase reaction. Green arrow indicates the promoting activity. Red arrow 
indicates the inhibitory activity. 
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The level of acute-phase proteins changes rapidly in response to inflammation, and these 
proteins serve as useful indicators of stress and disease. The APPs are mainly synthesized 
and secreted from the liver, under cytokine stimulation (Fig.1 is from ref.7). These cytokines 
can drive the production of anti-inflammatory glucocorticoids by regulating the 
hypothalamic-pituitary-adrenal (HPA). 
 
 
Fig. 2. The summary of acute phase protein production. 
The three most common APPs are C-reactive protein (CRP), serum amyloid A (SAA) and 
serum amyloid P (SAP). Many other APPs have been found, and they all play important 
roles. According to the report (7), the APPs are stimulated by the release of cytokines such 
as IL-6 (Fig. 1), which is induced locally and systemically. APPs have showed a correlation 
with markers of oxidative stress (8). If the tissue damage stimulation has repeated pulses, 
the acute-phase reaction can become chronic. The chronic inflammation can continuously 
provide the increasing serum APPs. Some APPs would be expressed in the liver, stimulated 
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by injury; APP expression might also be a promoter of a benign or malignant tumor, such as 
SAA in ovarian tumors, and may trigger the tissue disorder. Acute-phase SAA is 
synthesized in the liver; extrahepatic production of SAA has been observed in several 
mammalian species (9). Based on these findings, the production of APPs can be summarized 
as in Fig. 2. 
In addition to the production of acute-phase protein, other physical responses would 
happen during the acute-phase response. They are listed in Table 1 (Table is from  
ref.10). Acute-phase phenomena may be included in a large number of behavioral, 
physiological, biological and nutritional changes. APPs can be induced under all of these 
phenomena. 
 
 
Table 1. Other acute phase phenomena 
2. Acute-phase proteins (APPs) 
Currently, numerous proteins are considered APPs, human APPs are listed in Table 2 (10). 
(Table 2 is from ref.10). The proteins can serve as inhibitors or mediators of the 
inflammatory processes. These proteins are a large and varied group of glycoproteins that 
would appear in the bloodstream and would be unrelated to immunoglobulin being 
responsive to inflammatory reaction (11). 
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Table 2. Human acute phase proteins 
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2.1 Classification of acute-phase proteins (APPs) 
Based on the protein concentration in plasma, APPs can be divided into two classes. 
2.1.1 Negative acute-phase protein 
APPs are produced by the liver and have an increased concentration in the serum. When 
APP concentration in the serum is decreased, the APPs are called negative APPs. Albumin, 
transferrin, transthyretin and retinol-binding protein (vitamin A binding protein, RBP) have 
been found as negative APPs (12). In chronic inflammation in humans, especially in 
developing countries, vitamin A deficiency is serious (13, 14). It is well-known to have a 
negative feedback effect on immunity. As this stress, nutrient deficiency, RBP would be 
reduced. 
2.1.2 Positive acute-phase proteins 
When APP concentration in the serum increases, the APPs are called positive APPs. They 
include such proteins as CRP, mannose-binding protein,-1 antitrypsin, etc, as listed in 
Table 3 (Table is from ref.5). The overall changed APP concentration in the serum includes 
negative and positive APPs. The APP pattern may vary from one species to another. Serum 
amyloid p-component (SAP) is an APP in mice but not in humans. Age may also be a factor. 
For example, some APPs exist in the infant stage normally, but they may not be found in 
adults. Furthermore, some APPs would be increased in some species but decreased in 
others. Transferrin is a negative APP in most mammalian species, but it is a positive APP in 
chickens (15). According to the report of González et al., (16), they mentioned that the serum 
albumin would be decreased significantly at 48h and a lot of APPs would be increased, such 
as fibrinogen, SAA and Hp etc. However, there has no evidence to conclude the correlation 
between albumin and induction of positive APPs.  
 
 
Table 3. Major positive and negative acute phase reactants in mammals and birds. 
2.2 The function of APPs 
The function of APPs has not been completely clarified. In general, the positive APPs serve 
different physiological functions in the immune system and in regulating and trapping 
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infected microorganisms and their products. In addition, the alteration of APP production 
can serve a useful purpose in inflammation, healing to injury or adaptation to infection. For 
example, the concentration of C-reactive protein (CRP) in serum rose significantly under 
acute-phase reaction; it is referred to as an acute-phase protein. It can participate in 
inflammatory response by inducing production of inflammatory cytokines and display anti-
inflammatory effects (17). CRP, characterized as a calcium-dependent binding to various 
substrates, such as DNA or cellular proteins, increases dramatically in response to tissue-
destructive processes (18). Currently, CRP has been found in direct stimulation of 
angiogenesis and may play a role in vessel formation (19). It indicates that APPs have 
multiple functions in the biosystem. 
2.3 Regulation of APPs 
Acute-phase reaction (APR) is a systemic response to injury and/or infection associated 
with endocrine and metabolic changes, including alteration of behavior, body temperature, 
production of cytokines and induction of APPs. Inflammatory cytokines, produced by 
inflammatory cells, are induced locally and systemically. The inflammatory mediators 
activate many cells and trigger a systemic release of cytokines (as pro-inflammatory 
cytokines). The increased serum-cytokines would result in the production of APPs. IL-1, 
TNF, INF- are major and important cytokines for the expression of inflammatory 
mediators to induce the production of cytokines from the liver, such as IL-6. It is the major 
mediator of liver secretion of many APPs. In mammals, APR activities are enhanced 
indirectly by the activation of the pituitary (Fig. 1). As the APR occurring, increase of the 
glucocorticoids is a result of cytokine secretion from the pituitary. The human acute phase 
serum amyloid A (SAA), a positive acute phase protein, was up-regulated significantly after 
stimulation by glucocorticoid and cytokine in human hepatoma cells (20). Besides, many 
non-hepatic cell types including monocytes, endothelial cells and others have been shown to 
express SAA in high levels when stimulated with cytokines and glucocorticoids (21). This 
indicates that cytokines and glucocorticoids regulate the synthesis of APPs (22). 
Glucocorticoid can be a positive and negative regulator of APP synthesis during APR 
(Scheme 1 is from ref.22).  
To our knowledge, cytokines are released from an injury or pathogen’s infection site. The 
proinflammatory cytokines, TNF, IL-1 and IL-6, are considered the primary mediators of the 
APR. Upon injury or infection, macrophage or circulating monocytes are activated; they 
release cytokines locally and stimulate the liver to synthesize the APPs. At the same time, 
these early responsive pro-inflammatory cytokines can also activate the 
hypothalamus/adrenal cortex and induce fever and synthesis of glucocorticoids. 
Glucocorticoids have been proved to enhance the cytokine-dependent APPs’ synthesis in the 
liver during APR. Numerous studies have provided evidences that glucocorticoids clearly 
show positive effects on APP synthesis during APR by way of a synergistic enhancement of 
pro-inflammatory cytokine effects (23–25). 
APPs are almost glycosylated and change with their structure of side sugar chain during 
different inflammatory processes (11). Glycosylation changes in APPs could be markers of 
disease. As an example, -1-acid glycoprotein (AGP) is an APP and has expressed more 
sialyl Lewis X (SLex) linkages in pancreatic cancer (PaC) tissue than in inflamed pancreatic 
tissue; however, the SLex linkages were barely detected in healthy pancreatic tissue (26). 
This reveals that the glycosylation of APPs can regulate the function of APPs. 
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Scheme 1. Activation of the AP response 
The cytokine-mediated network linking the inflammatory site and target organs/tissues is 
shown. Following exposure to the stimulating agent, cytokines produced by macrophages 
act on neighbouring cells, e.g. leucocytes (monocytes, neutrophils and lymphocytes) and 
endothelial cells, in the vicinity of the inflamed sites. These cells themselves become 
activated and express additional cytokines and receptors. Endothelial cells express selectins 
( ) which recruit circulating leucocytes and platelets from the bloodstream. Cytokines 
released to the circulation induce the hepatic AP response, which involves the increased 
synthesis of AP proteins e.g. A-SAA, C-reactive protein and complement components. 
Stimulation of the central nenrous system by cytokines induces fever and the synthesis of 
glucocorticoids by the adrenal cortex. Glucoconicoids enhance the hepatic AP response and 
at the same time feed back to down-regulate the local inflammation (open arrow) and its 
systemic inflammatory consequences. 
3. Acute phase index 
During the APR, there is an increase in APPs (positive APPs) and there are decreases in 
some APPs (negative APPs); the quantification of these proteins provides valuable clinical 
information in diagnosis and treatment. Numerous researchers have developed the method 
in animals to assess-nonhealthy animals versus healthy ones, and the calculating index is 
called the “acute phase index” (6, 27). 
 
 
(Eq. is from ref.6) 
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In general, the calculated indexes were significantly higher in nonhealthy animals than in 
normal ones, and decreased indexes were observed after treatment. For calculating the 
indexes, the ratio between positive and negative acute-phase proteins has to the determined. 
If the ratio is combined with those of rapid and slow changes in positive and negative APPs, 
the acute-phase signal can be enhanced. The index has been used as a prognostic 
inflammatory for human patients, who might also have a nutritional deficiency. 
Determination of the index with several APPs can help in monitoring the health of 
individual subjects. 
Before calculating the index, the protein concentrations have been measured quantitatively. 
Many technologies, such as the protein chip, the protein microarray method or quantitative 
polymerase chain reaction (qPCR), can be used for APP measurement. These technological 
developments should have crucial importance in future diagnostics. 
4. Acute-phase proteins related to oxidative stress 
The reactive oxygen species (ROS) in the environment indicates the stress status. It has been 
implicated in inflammation. Elevation of ROS induces gene expression, which is involved in 
inflammatory and acute-phase responses (28, 29). It indicates the stress will trigger the APR 
and the occurrence of APPs synthesis. For example, patients with pressure sores present a 
systemic inflammatory response associated with the decrease of ascorbic acid levels, 
suggesting that the patient may be nutritionally deficient (30). Nutritional deficiency is a 
kind of stress in vivo and triggers the elevation of the ROS level. The high ROS level in vivo, 
known as an acute-phase status, includes alternations of APPs and is related to cell 
apoptosis. These may contribute to the development of pressure sores in patients and may 
impede the wound-healing process. 
Infections are also associated with elevating the intracellular oxidative stress via the reaction 
of proinflammatory cytokines. The bactericidal factors and the inflammatory response 
confer oxidative stress to the cells that may lead to cell apoptosis. This means APR was 
developed by infections and initiated an increase in oxidative stress and possibly triggered 
cell apoptosis via APPs (31). For example, LCN2 could induce the increase of intracellular 
ROS significantly within a short time, upon the protein interaction with the cells and 
suppression by the ROS inhibitor (Fig. 3) (32). 
This protein has been described as being mainly expressed in tissues that may be exposed to 
microorganisms (33), or detected in acute inflammatory response (34) in keeping with these 
conditions’ stress status. Cowland et al. (35) showed that during lung inflammation, the 
human LCN2 protein (also called Neutrophil Gelatinase Associated Lipocalin; NGAL or 
human 24p3 protein) synthesis increases in the bronchial epithelial cells, so it was 
considered as a disease activity marker (36, 37). All of these imply that the LCN2 protein 
correlates with environmental stress and tissue damage. In cultured cells, the LCN2 protein 
increment is observed in response to glucocorticoid stimulation, and also in other conditions 
such as serum deprivation. Elevating the glucocorticoid level in circulation during stress 
may trigger the LCN2 protein being highly expressed under this stress condition and exert 
an autocrine control (38) during stress, thus playing a role in cell death (39). Over the years, 
ROS has been perceived as a biological hazard, causing oxidative damage to the cellular 
components, and leading to cancer, cell degeneration and disorders related to aging (40). 
www.intechopen.com
 Characterization of Acute - Phase Proteins (APPs) 
 
307 
Based on the descriptions, APPs may initiate the aberrant cell growth under stress 
conditions. 
In general, we have known that cytokines are stimulators of most APPs’ synthesis during 
APR. At the same time, APP is also a stimulator of cytokine production as cells are 
responsive to the APP. Exposure of endometrial carcinoma cell line (RL95-2) to LCN2 for 
>24 h reduced LCN2–induced cell apoptosis, changed the cell proliferation and up-
regulated cytokine secretions, including: interleukin-8 (IL-8), inteleukin-6 (IL-6), monocyte 
chemotatic protein-1 (MCP-1) and growth-related oncogene (GRO) (Fig. 4) (41). These 
cytokines may change the growth of the cells. 
 
 
Fig. 3. Induction of ROS by 24p3 protein (also called mouse LCN2) treatment. RL95-2 cells 
were treated with 5μM 24p3 protein for various time intervals, followed by incubation with 
20μM DCFH-DA for 15 min. The amount of intracellular ROS can be quantified by detection 
via a microfluorometer with excitation and emission wavelengths at 485 and 535 nm, 
respectively. The results were confirmed in multiple experiments and presented as the 
mean±S.D. (**) p < 0.01, (***) p < 0.001, n = 5. (A) The time course of 24p3 protein effect on 
RL95-2 cells. (B) The DPI prevents the 24p3 protein from inducing ROS in RL95-2 cells. The 
black bar indicates the 30-min incubation and the gray bar indicates 60-min incubation of 
24p3 protein with the cells. 
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Fig. 4. Cytokine array analysis of conditioned medium from Lcn-2-treated RL95-2 cells. 
(A) RayBio® Human Cytokine Antibody Array I Map. (B) The signals of cytokine 
concentrations in conditioned media; significant signals are labeled with Arabic numerals: 1, 
MCP-1; 2, IL-6; 3, IL-8; and 4, GRO. Relative intensities of these four cytokines are shown in the 
lower panels with the intensities of values from control serum-free media set as 1. (C) mRNA 
levels of cytokines in Lcn-2-treated cells. A total of 4×104 cells were incubated with or without 
10 μM Lcn-2 in serum-free medium for 24, 36 and 48 h. After incubation, the total RNA 
isolated from cells was reverse transcribed and amplified by RT-PCR using primers for MCP-
1, IL-6, IL-8 and GRO. Levels of mRNA were determined by semi-quantitative RT-PCR. 
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However, IL-8 mRNA and protein levels were dramatically increased in LCN2–treated 
RL95-2 cells. The major focus was to determine the IL-8 effect on LCN2-treated RL95-2 cells. 
Adding recombinant IL-8 (rIL-8) resulted in decreased caspase-3 activity in LCN2–treated 
cells, whereas the addition of IL-8 antibodies resulted in significantly increased caspase-3 
activity and decreased cell migration. Data indicate that IL-8 plays a crucial role in the 
induction of cell migration (Fig. 5) (41). 
 
 
Fig. 5. Effects of LCN2-conditioned medium on RL95-2 cell migration. RL95-2 cells were 
stimulated with LCN2 for varying lengths of time, and then culture supernatants were 
collected from conditioned medium. Cytokine antibodies (anti-IL-8 or anti-IL-6) were added 
to clarify the effect of these cytokines on 48 h CM-induced cell migration. Cell migration was 
measured using the transwell assay in the absence or presence of conditioned medium. (A) 
After incubation for 24 h, RL95-2 cells were stained with 0.5% crystal violet, and cells were 
counted in ten random fields under a microscope at X20 magnification. (B) OD570 values of 
cells on the lower surface of the membrane extracted with 33% acetic acid after anti-IL-8 
neutralization. These data are representative of three independent experiments. The cell 
number of RL95-2 incubation under 48 h CM for 24 h is as a control experiment. Values are 
the mean ± SEM. **, P < 0.01; ***, P < 0.001. 
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Interestingly, LCN2-induced cytokines, secretion from RL95-2 cells, could not show the 
potent cell migration ability with the exception of IL-8. We concluded that LCN2 triggered 
cytokine secretions to prevent RL95-2 cells from undergoing apoptosis and subsequently 
increased cell migration. We hypothesize that LCN-2 increased cytokine secretion by RL95-2 
cells, which in turn activated a cellular defense system. This means the APP would secrete 
from the cell under stress and then promote the secretion of cytokines and enhance cell 
growth. 
5. Acute-phase proteins related to cytokines 
Furthermore, tumorigenesis and the invasion capacity of tumor cells are medicated by 
growth factors, including cytokines, which promote cell proliferation, including the invasion 
of tumor cells. Cytokines are a part of homeostasis, stress response, inflammation and 
tumorigenesis (42). IL-6 is known to be a proinflammatory cytokine. The elevation of IL-6 
levels in patients with a Ras-induced cancer can trigger the other secreting cytokine, IL-8, an 
important factor for tumor growth in HeLa cells. It provided the information linking 
cytokines to tumorigenesis and also hinted at the linkage of APPs to tumorigenesis (43–46). 
IL-8 can be induced in endometrial cells by an acute-phase protein, LCN2, also an 
angiogenic factor in some cancers (47). According to the report of Arenberg et al., (37) 
inhibition of IL-8 expression would reduce the tumor development of human lung cancer in 
mice. It was announced that the IL-8 plays role in mediating angiogenesis during 
tumorigenesis of human cancer. IL-8 thereby offers the potential to promote the formation 
of tumor (48). Based on the result of Lin et al. (41), LCN2 could induce IL-8 expression and 
secretion and enhance cell migration and invasion. This suggests IL-8 as an LCN2-induced 
tumor factor. It indicates that the LCN2-induced IL-8 secretion from uterine endometrial 
cells and promotes the cell migration therefore the result provides evidence for APP playing 
a role in tumorigenesis. 
6. Acute-phase proteins as tumorigenic factors or diseases inducers 
APPs may initiate tumor formation indirectly via induced cytokines, or/and directly by 
themselves. To our knowledge, serum amyloid A (SAA) is an APP; it has been found that it 
may contribute the role in directing and enhancing the tumor process. Especially, numerous 
studies on SAA had been focused on the tumor progression. 
The acute-phase serum amyloid A proteins (SAAs) are multifunctional proteins that would 
be up-regulated by proinflammatory cytokines during inflammation, infection, trauma or 
stress. Several biological effects of SAA have been described in relation to inflammation, 
including cell adhesion, cell migration, tissue infiltration of inflammatory cells, enhancing 
matrix metalloproteinases (MMPs) increasing expression of cytokines, or stimulating 
angiogenesis. The liver is the main site for SAA synthesis; however, extra hepatic expression 
has been found in many normal human tissues (20). In more recent studies, SAA in serum 
levels were found elevated in a wide range of cancers. SAA is expressed locally in colon 
carcinoma and also overexpression in endometrial carcinoma and ovarian tumors (49). 
Breast cancer is one of the most common cancers in women worldwide. Finding the 
potential biomarkers to identify the types of breast cancer is an important work in progress. 
LCN2 is a newly identified biomarker for breast cancer; clarification of the possible 
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mechanisms underlying its role in tumorigenesis is ongoing. LCN2, originally an 
inflammatory marker in both adipose and liver tissue (50), can be induced by 
lipopolysaccharides, suggesting that LCN2 is an acute-phase protein as in previous 
mentioned. However, increased systemic LCN2 levels in several diseases have been 
reported, such as chronic renal failure, chronic inflammation and some cancers. This may 
reveal that APPs play multi-functions in the biological system. 
6.1 Endometrial hyperplasia 
Human LCN2 (NGAL) is also found in human endometrial hyperplasia, a uterine disorder 
disease. Up-regulation of NGAL protein and mRNA was much higher in endometrial 
hyperplasia than in adenomyosis. Endometrial carcinoma is more often associated with 
endometrial hyperplasia (55%) than with endometrial adenomyosis (16%) (51). It seems to 
 
 
 
Fig. 6. Western blot analysis of NGAL in biopsy samples of endometrial disorders and 
immunohistochemical staining of endometrial adenomyosis and hyperplasia samples with 
anti-NGAL. A. Immunoblotting with anti- NGAL and anti-GAPDH. The data represent the 
mean ± SEM from all biopsies (eight adenomyosis samples and 27 hyperplasia samples), 
and were calculated using the ratio of NGAL to the internal control (GAPDH). The right 
panel shows the signal after immunoblotting. B. NGAL immunoreactivity was not observed 
in adenomyosis in the presence of the NGAL antibody (b). Similarly, no NGAL expression 
was observed in either tissue in the absence of NGAL antibody (a, c). However, in the 
presence of NGAL antibody, strong NGAL expression was observed as a light brown color 
in the cytoplasm of glandular epithelia (GE) in endometrial hyperplasia (arrows). The nuclei 
were stained with hematoxylin (blue). Magnification x100 and x400 (inset). 
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indicate that endometrial hyperplasia itself presents a higher risk for progressing to 
endometrial carcinoma compared to adenomyosis. Therefore, we asked whether the cancer 
marker NGAL was responsive to tumorigenic transformation of endometrial hyperplasia 
and if it was expressed at high levels. Immunohistochemical analysis revealed that NGAL 
expression in the glandular epithelia was strongly elevated in endometrial hyperplasia 
compared to adenomyosis (Fig. 6) (52). Some studies have shown that NGAL can be a 
marker for ovarian, breast, bladder, and pancreatic cancers, and that it is a survival factor 
for thyroid neoplastic cells (53–55). 
Consistent with our findings, a significant increase in NGAL expression in endometrial 
hyperplasia may be a part of the tumorigenic process. Therefore, we propose an autocrine 
function for NGAL, which may play a role in uterine disorders or carcinomas. Previous 
studies have suggested that NGAL overexpression may be required for tumorigenesis by 
promoting tissue invasion (56). Based on these studies, it seems likely that NGAL is related 
to the transition from endometrial hyperplasia to endometrial carcinoma. The data showed 
that NGAL expression was significantly increased in endometrial hyperplasia compared to 
adenomyosis and correlated positively with COX-2 expression (r = 0.42). The increased 
COX-2 expression in hyperplasia may signify an early step in carcinogenesis. These uterine 
disorders may be inflammatory disorders and may trigger COX-2 gene expression. COX-2 is 
also important during tumorigenic transformation of hyperplasia (57, 58), where it decreases 
endometrial cell apoptosis and increases angiogenesis. It is the evidence for the correlation 
of APP with disease. 
6.2 Endometriosis 
Endometriosis, which usually develops in pelvic organs such as the ovaries and may 
contribute to infertility, is an estrogen-dependent disease characterized by the presence of 
endometrium-like tissue outside the uterine cavity (59). A relationship between ovarian 
endometriosis and certain types of ovarian cancer has been suggested, and endometriosis is 
believed to increase cancer risk. Endometriosis is similar to cancerous tumors in that it 
requires angiogenesis for expansion (60–62). Epithelial-mesenchymal transition (EMT) is a 
process whereby epithelial cells are converted to a mesenchymal phenotype and may be 
essential for the migration, invasion and relocalization of epithelial cells (59). EMT also can 
be induced by other signals, including the acute stress response (63). We hypothesized that 
EMT might be involved in the development of endometriosis. LCN2 is an oxidative stress 
factor that responds to environmental stress and triggers changes in cellular physiology. 
This signaling pathway may be activated under physiological as well as pathophysiological 
conditions (64). Cannito et al. found that intracellular ROS also are involved in the 
regulation of EMT (64), and Yanga et al. (65) found that LCN2 is associated with breast 
cancer progression via EMT. In addition, LCN2 also triggered cell migration and invasion 
(Fig. 7) (unpublished data), and this effect might contribute to the development of ectopic 
endometrial tissue implantation. Based on our evidence, we propose that LCN2 induces 
EMT in endometrial epithelial cells under nutrient-deprived conditions and thereby 
promotes the development of endometriosis. 
In summary, during inflammation or stress, APPs can be induced by proinflammatory 
mediators and trigger the changes in cell physiological balance. Actually, cell apoptosis and 
cell proliferation are involved in the APPs triggered pro-inflammatory (cell apoptosis) or 
anti-inflammatory (wound-healing). According to Khatami's theory (66-68), acute phase 
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response is a highly regulated immune response to achieve a well-balance of cell death and 
cell growth in biological system; and indicates the APPs reaction is a kind of "Yin-Yang" 
doctrine. Therefore, the regulation of inflammatory response could initiate the challenge to 
the balance of tumoricidal versus tumorigenesis in immune system. The alteration of 
balance is considered as factor for causing the diseases; however, the regulatory pathways 
of APPs in disease formation remain unanswered. Future elucidation of the complex 
network of APPs, cytokines and pathological conditions is essential. The knowledge of APPs 
might be useful for providing an important method to monitor mammalian health. 
 
 
 
Fig. 7. Endometrial epithelial cell migration assays. Primary endometrial epithelial cells 
were harvested and then cultured in 1% FBS/DMEM/F12 medium for 48 h. The medium 
was collected and centrifuged to remove the suspended cells and cell debris and was used 
as a conditioned medium. Conditioned medium with or without 0.02 M LCN2 antibody 
was used for wound-healing experiments and the Transwell assay. A, Wound-healing assay. 
Endometrial epithelial cells (5 × 104) were cultured in 24-well plates for 48 h until near 
confluence (～90%). A sterile 200-l pipette tip was used to scratch through the cells to 
simulate a wound. After conditioned medium was added, the scratches were observed 
microscopically over a 12-h period. The green lines indicate the edge of each side of the 
scratch to show cell migration. B, C, Transwell assay. Endometrial epithelial cells (1 × 105) in 
100 l 1% FBS/DMEM/F12 medium were added to Transwell units. Conditioned medium 
(400 l) was then added, and cells were allowed to migrate for 24 h in a 37˚C, 5% CO2 
incubator. After incubation, the cells in the membrane insert were stained as described in 
the text and visualized (C); cells were then counted (B). 
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